TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 216 filers reported holding TG THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,252 | -62.1% | 389 | +12.8% | 0.00% | -100.0% |
| Q2 2023 | $8,570 | +72.7% | 345 | +4.5% | 0.00% | 0.0% |
| Q1 2023 | $4,963 | +38.5% | 330 | +8.9% | 0.00% | – |
| Q4 2022 | $3,584 | +258.4% | 303 | +203.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 100 | -70.6% | 0.00% | – |
| Q2 2022 | $1,000 | -75.0% | 340 | -14.4% | 0.00% | -100.0% |
| Q1 2022 | $4,000 | -81.0% | 397 | -64.5% | 0.00% | -66.7% |
| Q4 2021 | $21,000 | -74.7% | 1,118 | -55.3% | 0.00% | -86.4% |
| Q3 2021 | $83,000 | -28.4% | 2,500 | -16.7% | 0.02% | -15.4% |
| Q2 2021 | $116,000 | -7.2% | 3,000 | +15.4% | 0.03% | -7.1% |
| Q1 2021 | $125,000 | +60.3% | 2,600 | +73.3% | 0.03% | +47.4% |
| Q4 2020 | $78,000 | +188.9% | 1,500 | +50.0% | 0.02% | +171.4% |
| Q3 2020 | $27,000 | +42.1% | 1,000 | 0.0% | 0.01% | +16.7% |
| Q2 2020 | $19,000 | +137.5% | 1,000 | 0.0% | 0.01% | +100.0% |
| Q1 2019 | $8,000 | +100.0% | 1,000 | 0.0% | 0.00% | +50.0% |
| Q4 2018 | $4,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |